Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gordon Schanzlin New Vision Institute is a premier ophthalmology and refractive surgery center based in San Diego, California. The institute specializes in advanced vision correction procedures, including LASIK, PRK, and laser cataract surgery using premium intraocular lenses. Beyond refractive surgery, the center provides comprehensive eye care services for conditions such as glaucoma, corneal diseases, and dry eye syndrome. Known for its involvement in clinical trials and the early adoption of ophthalmic technologies, the institute serves as a leading provider of surgical and medical eye care. In 2021, the practice was acquired by Vision Innovation Partners, a leading ophthalmology management services organization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gordon Schanzlin New Vision.